Natus Medical Incorporated develops, manufactures, and markets neurodiagnostic and newborn care products. Its products are used for the screening, detection, treatment, monitoring, and tracking of common medical ailments, such as hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and newborn care. The company offers newborn hearing screening products, including the ALGO, ABaer, AuDX, and Echo-Screen newborn hearing screeners; diagnostic hearing assessment products consisting of the Navigator Pro system, the Scout Sport portable diagnostic device, the HINT PRO, the AuDX PRO, and its Cochlea-Scan, which are used to screen or diagnose hearing loss, or to identify abnormalities affecting the peripheral and central auditory nervous systems; and monitoring systems for neurology products. It also provides a range of products for the contemporary sleep laboratory, including laboratory systems, portable systems, and ambulatory recorders for home monitoring; newborn care products comprising products to diagnose and treat newborn brain injury; and phototherapy lights to treat newborn jaundice. In addition, the company offers medical devices, including photometers, patient warming lamps, pediatric scales, blanket warming cabinets, exam lights, transilluminators, oxygen hoods, and heat shields; disposable supplies, such as neonatal noise attenuators, phototherapy eye masks, restraining boards, and x-ray shields for newborn gonads; and newborn screening data management systems. Further, it provides software systems for managing and tracking disorders and diseases for public health laboratories. The company’s customers include hospitals, clinics, laboratories, physicians, nurses, audiologists, and governmental agencies. It sells its products through a direct sales force primarily in the United States, as well as through distributors worldwide. The company was founded in 1987 and is headquartered in San Carlos, California.